Skip to main content
Fenny H.F. Tang on Muck Rack

Fenny H.F. Tang

As seen in: The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fenny H.F.

Contact Fenny H.F., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

First-generation and preclinical evaluation of an EphA5-targeted antibody-drug conjugate in solid tumors

|
By Fernanda I Staquicini, Fenny H.F. Tang, Vanessa de Oliveira, Sun-Young Kim
| The Journal of Clinical Investigation
Abstract Contemporary cancer treatment strategies are shifting toward targeted therapies to improve efficacy and minimize toxicity. Here, we report the design and preclinical evaluation of MBRC-101, a first-in-class antibody-drug conjugate (ADC) targeting EphA5, a receptor tyrosine kinase with an established role in embryonic development but not extensively studied in cancer.
Open in Who Shared Issue with article?
See all 1 articles